BioSpace News Archive

Canopy Growth Corporation is proud to announce that it will contribute CDN $2.5 million to the University of British Columbia (“UBC”) and BC Centre on Substance Use (“BCCSU”) to fund research into the potential utility of cannabis in addressing the overdose crisis.

Novel, Oral Fumarate Therapy Intended to Provide a Differentiated Gastrointestinal Tolerability Profile

Seasoned Executive Gerard Fleury Joins the Company as Chief Financial Officer

Protagonist Therapeutics, Inc. announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will provide a corporate overview at the 2018 JMP Securities Life Sciences Conference

Data-sharing program helps keep shared patients transplant-ready [06-June-2018] CHICAGO, June 6, 2018 /PRNewswire/ -- DaVita Kidney Care , a division of DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States, and the University of Chicago Medicine today announced the successful implementation of the Transplant Waitlist Sup

Now clinicians can order genomic tests through DrFirst’s Rcopia e-prescribing tool to learn how patients’ genes will impact medication effectiveness for optimal treatment results

The National Evaluation System for health Technology Coordinating Center (NESTcc) has established a Data Quality Subcommittee and a Methods Subcommittee to support its efforts to conduct efficient, timely, and high-quality real-world evidence studies for medical devices.

~ Conference call for analysts to be held at 2:30pm BST / 9:30am ET (see details below)

Torben Straight Nissen, Rubius’ President, will partner with Dr. Cagnoni to continue to advance the company’s pipeline and other business objectives.

Improves survival when initiated 48 hours after radiation exposure